General advisory related to food, drugs and biotechnology regulations

Legal structuring of transactions involving food, drugs and biotechnology assets

Regulatory compliance related to good practices standards, including issues related to labelling, advertising and commercialization and food and drugs

General representation before regulatory agencies overseeing the commercialization, pricing and production of assets subject to sanitary and health surveillance rules

Agreements and protocols related to clinical trials, including bioethics issues and relationship with contract research organizations, clinical centres and monitors, as well as with bioethics and clinical trial regulators

General advisory related to new and projected rules for compound technologies, such as semiconductors, nanotechnology and clean-technology products

Biotechnology, food and drugs dispute resolution